Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness by Cunningham MO et al.
Neurobiology of Disease
Region-Specific Reduction in Entorhinal Gamma Oscillations
and Parvalbumin-Immunoreactive Neurons in Animal
Models of Psychiatric Illness
Mark O. Cunningham,1 Jillian Hunt,1 StevenMiddleton,2 Fiona E. N. LeBeau,1Martin G. Gillies,1 Ceri H. Davies,3
Peter R. Maycox,3Miles A. Whittington,1 and Claudia Racca1
1School of Neurology, Neurobiology, and Psychiatry, University of Newcastle, Newcastle NE2 4HH, United Kingdom, 2Faculty of Biological Sciences,
University of Leeds, Leeds LS2 9NQ, United Kingdom, and 3Psychiatry Center of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, Essex,
CM19 5AW, United Kingdom
Psychiatric illnesses, particularly schizophrenia, are associated with disrupted markers for interneuronal function and interneuron-
mediated brain rhythms such as gamma frequency oscillations. Herewe investigate a possible link between these two observations in the
entorhinal cortex and hippocampus by using a genetic and an acute model of psychiatric illness. Lysophosphatidic acid 1 receptor-
deficient (LPA1-deficient) mice show psychomotor-gating deficits and neurochemical changes resembling those seen in postmortem
schizophrenia studies. Similar deficits are seen acutely with antagonism of the NMDA subtype of glutamate receptor. Neither model
induced any change in power or frequency of gamma rhythms generated by kainate in hippocampal slices. In contrast, a dramatic
decrease in the power of gamma oscillations was seen in superficial, but not deep, medial entorhinal cortex layers in both models.
Immunolabeling for GABA, parvalbumin, and calretinin inmedial entorhinal cortex from LPA1-deficientmice showed an40% reduc-
tion in total GABA- and parvalbumin-containing neurons, but no change in the number of calretinin-positive neurons. This deficit was
specific for layer II (LII). No change in the number of neurons positive for these markers was seen in the hippocampus. Acute NMDA
receptor blockade, which selectively reduces synaptic drive to LII entorhinal interneurons, also disrupted gamma rhythms in a similar
manner in superficial entorhinal cortex, but not in hippocampus. These data demonstrate an area-specific deficit in gamma rhythmo-
genesis in animal models of psychiatric illness and suggest that loss, or reduction in function, of interneurons having a large NMDA
receptor expression may underlie the network dysfunction that is seen.
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Introduction
Schizophrenia (and related psychiatric illnesses) is associated
with a number of quantifiable changes in cognitive performance,
neurochemistry, psychophysiology, and neuroanatomy. Deficits
in working memory (Park and Holzman, 1992) and sensorimo-
tor gating (Geyer and Braff, 1987; Braff et al., 1992) are seen, with
the magnitude of reduction correlating with the severity of psy-
chosis (Meincke et al., 2004). Neurochemical changes involve
monoaminergic, glutamatergic, and GABAergic systems (Wein-
berger, 1997). Psychophysiological changes include deficits in
mismatch negativity, a component of (usually) auditory evoked
potentials related to gamma frequency EEG activity (Marshall et
al., 1996).Gamma rhythms are disrupted both in their generation
and the cortical synchrony they facilitate during sensory stimu-
lation (Spencer et al., 2003, 2004). Neuroanatomical changes in-
clude a disorganized arrangement of stellate cells in entorhinal
cortex (Falkai et al., 2000) and changes in markers for interneu-
ron function, particularly interneurons containing parvalbumin
(for review, see Arnold, 2000; Lewis et al., 2005).
No animal models are available that capture all of these as-
pects of schizophrenia and related psychoses. However, some
models are available that display some or many of these deficits.
Sensorimotor-gating deficits are seen in mGluR5 (Brody et al.,
2004) and lysophosphatidic acid 1 receptor (LPA1) knock-out
mice (Harrison et al., 2003) and mice with mutations in proline
dehydrogenase or reelin (Gogos et al., 1999; Tueting et al., 1999).
Psychosis induced by the NMDA receptor antagonist ketamine is
associated with sensorimotor-gating deficit in humans and rats
(de Bruin et al., 1999; Oranje et al., 2002). In addition, LPA1
receptor knock-out mice show many neurochemical changes as-
sociated with postmortem analysis of brains from schizophrenics
(Roberts et al., 2005), and ketamine models both the hyperdo-
pamine and hypoglutamate putative mechanisms of schizophre-
nia (Seeman et al., 2005).
A number of lines of evidence implicate the entorhinal cortex
as a site for dysfunction in schizophrenia and related psychiatric
illnesses (Arnold, 2000). Sensorimotor gating involves entorhinal
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cortical processing (Goto et al., 2002), and disruption in gross
anatomy is associated with positive symptoms of schizophrenia
(Prasad et al., 2004). At the cellular level changes in synaptic-
related marker mRNAs are found in entorhinal layers II/III (LII/
LIII) in postmortem brains from schizophrenics (Hemby et al.,
2002), peptide levels associated with interneurons are reduced
(Bachus et al., 1997), and developmental changes in LII neurons
are seen (Falkai et al., 2000). The medial entorhinal cortex gen-
erates gamma frequency oscillations in vivo, in the whole brain
preparation, and in vitro (Chrobak and Buzsa´ki, 1998; Dickson et
al., 2000; Cunningham et al., 2003). These oscillations are asso-
ciated with cognitive function via facilitation of entorhinal/hip-
pocampal interactions (Fell et al., 2001).
Gamma oscillations generated by metabotropic receptor acti-
vation (Whittington et al., 1995; Fisahn et al., 1998) involve syn-
chronous outputs from predominantly parvalbumin-positive,
fast-spiking interneurons (Gloveli et al., 2005). We therefore
wished to test whether a relationship between gamma power and
interneuron function exists in the entorhinal cortex and hip-
pocampus in two animal models of symptoms associated with
psychiatric illness, a developmental model involving the ablation
of the gene encoding the LPA1 receptor and an acute model
(ketamine) in entorhinal cortical/hippocampal slices.
Materials andMethods
Slices (450 m) containing hippocampus and entorhinal cortex were
prepared from young adult male LPA1 receptor knock-out mice
(LPA1/) and wild-type (WT) litter mates, as well as adult maleWistar
rats and C57BL/6Jmice. All procedures were performed according to the
requirements of the United Kingdom Animals Scientific Procedures Act
(1986). Animals were anesthetized with inhaled isoflurane, immediately
followed by an intramuscular injection of ketamine ( 100 mg/kg) and
xylazine ( 10 mg/kg). Animals were perfused intracardially with 50
ml ofmodified artificial CSF (ACSF), whichwas composed of the follow-
ing (in mM): 252 sucrose, 3 KCl, 1.25 NaH2PO4, 24 NaHCO3, 2 MgSO4,
2 CaCl2, and 10 glucose. All salts were obtained from BDH Chemicals
(Poole, UK). The brain was removed and submerged in cold (4–5°C)
ACSF during dissection. Horizontal slices were cut and transferred to a
recording chamber maintained at 34°C at the interface between ACSF
[containing the following (in mM): 126 NaCl, 3 KCl, 1.25 NaH2PO4, 24
NaHCO3, 2MgSO4, 2 CaCl2, and 10 glucose] and warm, moist carbogen
gas (95% O2/5% CO2). Slices were permitted to equilibrate for 45 min
before any recordings commenced. All slices (hippocampal and entorhi-
nal) were taken from an 2-mm-deep region containing medial ento-
rhinal cortex and temporal hippocampus (interaural, 2.56–4.36 mm;
bregma, –7.44 to –5.64 mm).
Recording electrodeswere pulled fromborosilicate glass (HarvardAp-
paratus, Edenbridge, UK), filled with ACSF, and had resistances in the
range of 2–5M (extracellular) and 50–100M (intracellular). Neuro-
nal subtypes were characterized electrophysiologically (interneurons
having fast, nonaccommodating spiking patterns and stellate cells having
a pronounced sag on injection of hyperpolarizing current) and anatom-
ically post hoc after biocytin injection. For stimulation experiments bipo-
lar platinum electrodes (25-m-diameter wire; tip separation, 200
m)were used to activate synaptic pathways electrically (60s duration;
1–10 V). The stimulation electrode was positioned in the superficial
layers of themedial entorhinal cortex. The following drugs were added to
the perfusion medium for various experimental conditions: bicuculline
methochloride (5 M), D,L-2-amino-5-phosphonovalerate (D-AP5; 50
M), 6-nitro-7-sulfamoylbenz-[S]-quinoxalinedione (NBQX; 10 M),
(2S)-3[[(1S)-1-(3,4-dichlorophenyl)-ethyl]amino-2-hydroxypropyl]
(phenylmethyl)phosphinic acid hydrochloride (CGP 55845A; 2 M), all
from Tocris Bioscience (Avonmouth, UK), plus kainic acid (200–400
nM) and ketamine (10–50 M) from Sigma–Aldrich (Poole, UK).
Peak frequency and power values were obtained from power spectra
generated with Fourier analysis in the Axograph software package (Mo-
lecular Devices, Sunnyvale, CA). Power for a given frequency band was
determined as the area under the peak in the power spectra between 20
and 80 Hz for gamma frequency oscillations. All values are given as the
mean SE where distributed normally; otherwise, data are expressed as
the median (interquartile range). Power spectra were constructed off-
line from digitized data (digitization frequency, 10 kHz), using a 60 s
epoch of recorded activity.Wemeasured the kinetics of EPSPs and IPSPs
with Mini Analysis (Jaejin Software, Leonia, NJ); we obtained 200
events per slice and pooled them for additional analysis.
Previously electrophysiologically characterized entorhinal cortex and
hippocampal slices from LPA1/ and WT were sandwiched between
twoMillipore filters (Bedford,MA) to avoid deformations andwere fixed
for 1–7 d in a solution containing 4% paraformaldehyde in PBS (0.1 M,
pH 7.4). Then these slices were gelatin-embedded and resectioned at 60
m thickness. Vibratome sections next were immersed for 20 min in 50
mM ammonium chloride in PBS and rinsed in PBS. Incubation in 10mM
sodium citrate in distilled water (dH2O), pH 8.4 (1 h, at 80°C), was used
to improve the labeling. This was followed by rinses in PBS, the quench-
ing of endogenous peroxidases with 0.3%H2O2 in 10%methanol in PBS,
and a blocking in 0.1% bovine gelatin/0.1% Triton X-100 in PBS. The
primary antibodies were prepared in the blocking solution (rabbit anti-
calretinin, 1:2000, Swant, Bellinzona, Switzerland; rabbit anti-
parvalbumin, 1:10,000, Calbiochem, La Jolla, CA; rabbit anti-GABA,
1:1000, Sigma–Aldrich). The sections were incubated for 48 h at 4°C.
After rinses the sections were incubated with biotinylated goat anti-
rabbit IgG (HL) (1:200; 2 h at room temperature; Vector Laboratories,
Peterborough, UK) in PBS, followed by ABC Elite Kit (1:200; 2 h at room
temperature; Vector Laboratories). The peroxidase reactionwas revealed
by incubating the sections in 0.05% 3,3-diaminobenzidine and 0.01%
H2O2. Sections were mounted on glass slides, dehydrated, and cover-
slipped with DPX (VWR Scientific, Poole, UK) before being examined
with a standard light microscope. Control experiments, in which the
primary antibody or each single step in the protocol was omitted, gave no
signal (supplemental material, available at www.jneurosci.org).
Quantifications were performed by various individuals, indepen-
dently, and blind to experimental conditions and to the origin of the
sections from LPA1/ or wild-typemice. Cells were considered immu-
nopositive when they showed a heavy brown labeling corresponding to
the peroxidase reaction product. Only positive cells were counted in
microscopic view fields at 10magnification within the 60 m sections
of the entorhinal cortex and hippocampus.
Results
Medial entorhinal cortex gamma rhythms
Bath application of 200–400 nM kainate generated persistent
field gamma rhythms in all layers of the medial entorhinal cortex
(mEC),with peak power in LII/LIII, as reported previously (Cun-
ningham et al., 2003). However, there was a marked reduction in
the kainate-induced gamma rhythms in superficial layers in slices
from LPA1/ mice (Fig. 1). In field recordings from LII the
gamma rhythm was almost absent in LPA1-deficient tissue (WT
area power, 303.9 73.0V2; LPA1/ area power, 85.5 33.3
V2; p 	 0.001; n 
 10), but what gamma remained was not
significantly different in frequency from that seen in slices from
WTmice (WT, 41.5 2.8Hz; LPA1/, 40.5 4.1Hz; p 0.05;
n 
 10). In contrast, gamma power in the deep mEC was not
significantly different in slices fromWT and LPA1/mice (WT
area power, 182.9  33.1 V2; LPA1/ area power, 138.1 
31.4 V2; p  0.05; n 
 10). No significant difference in fre-
quency of population gamma was seen in the deep layers (WT,
39.8 3.0 Hz; LPA1/, 28.5 7.0 Hz; p 0.05; n
 10).
Because gamma rhythms in the mEC are dependent on the
output from fast-spiking interneurons (Cunningham et al.,
2003), we examined the profile of IPSPs in principal cells in the
superficial layers to determine whether the reduction in the field
was accompanied by a reduction in phasic inhibitory input. Dur-
ing population gamma rhythms in WT slices the principal cell
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intracellular recordings typically took the formof rhythmic trains
of IPSPs. IPSPs were phase-locked to the local field potential
rhythm and occurred at the same frequency (Fig. 2). In cells from
LPA1/ mice the trains of IPSPs were far more erratic, with
Figure 1. Kainate-induced field gamma rhythms were disrupted in superficial mEC layers
but not in deep layers. A, Example field potential traces (0.5 s) showing oscillatory activity in
superficial layers II and III and deep layer IV/V in slices from control (WT) and LPA1/ (KO)
mice. The right panel shows pooled power spectra (n
 5) of 60 s epochs of field activity from
WT (solid line) and KO (dashed line) slices. Calibration: 0.05mV, 100ms.B, Bar graphs showing
pooled data (mean  SEM) from superficial (left panel) and deep (right panel) entorhinal
cortex. Note that only the area power (not the frequency) is changed significantly (*) when
slices fromWT and KOmice are compared.
Figure 2. Disrupted field gamma rhythms are associatedwith disrupted phasic inhibition in
superficial principal cells. A, The pattern of IPSP trains in LII stellate cells was disrupted in
LPA1/mice (KO) comparedwith controls (WT) at30mV. IPSPswere seen less frequently
and with more variable inter-IPSP intervals. Power spectra of IPSP trains showed a much re-
duced inhibitory gamma frequency input to these cells. WT data are plotted as a solid line; KO
data are plotted as a gray line. Calibration: 2mV, 50ms.B, Cumulative probability plots for IPSP
recordings showing a small but significant decrease in amplitude (left graph) and large increase
in interevent interval (right graph) in stellate cells during population gamma rhythms. KO data
are plotted as dashed lines. C, Stimulus–response relationship for monosynaptically evoked
IPSPs (eIPSPs) onto stellate cells in nonoscillating slices. At each stimulus intensity, the applied
IPSPamplitudes in slices fromLPA1/mice (KO)were30–50%smaller than those evoked
in control (WT) slices. Data are illustrated as mean SEM. Calibration: 5 mV, 10 ms.
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individual IPSPs occurring far less often than in cells from WT
mice and being of a smaller amplitude, on average. IPSPs seen
during gamma oscillations inWT slices had amean amplitude of
9.1 0.1 mV (at30 mV resting membrane potential). In slices
fromLPA1/micemean amplitudewas slightly smaller at 8.1
0.1 mV. Cumulative probability analysis of IPSP amplitude re-
vealed a highly significant difference ( p	 0.05; n
 4), although
the kinetics of these IPSPs was not significantly different in tissue
from the two types of mice (WT decay time, 37.3  4.7 ms;
LPA1/ decay time, 24.7  12.7 ms; p  0.05; n 
 4). Cumu-
lative probability analysis of inter-IPSP intervals revealed a highly
significant increase ( p 	 0.05; n 
 4) (Fig. 2B). To establish
whether these findings were attributable to a failure of the kainate
model to activate interneurons, we also recorded stimulus-
evoked IPSPs in principal cells under nonoscillating conditions
in which GABAB receptor-mediated and ionotropic glutamate
receptor-mediated events were blocked pharmacologically. At
three stimulus intensities (2.5, 5, 10V) delivered to the superficial
mEC proximal to the recorded principal cells, evoked IPSPs in
slices fromLPA1/micewere significantly smaller than those in
WT slices (Fig. 2C). Mean reduction in IPSP amplitude was
45.0  7.5% ( p 	 0.05; n 
 10). No alteration was seen in the
kinetics of evoked IPSPs in either condition.
Such a large reduction in both stimulus-evoked and oscilla-
tory GABAA receptor-mediated inhibition would be expected to
increase the excitability of principal cells in the superficial mEC.
In LII stellate cells (where the decrease in kainate-induced
gamma field power was largest) we saw an increase in ongoing
action potential generation during the gamma rhythm (Fig. 3A).
WT stellate cells generated action potentials with a frequency of
1.3 0.5 Hz, whereas stellate cells in slices from LPA1/mice
generated action potentials at 5.5  0.5 Hz ( p 	 0.05; n 
 4).
This increase in output was not accompanied by a significant
change in mean membrane potential during the gamma oscilla-
tion (WT membrane potential, 59  3 mV; LPA1/ mem-
brane potential, 56  3 mV; p  0.05; n 
 5). However, a
significant increase in input resistance was seen (LPA1/, 31
3 M; WT, 24  2 M; p 	 0.05; n 
 7) along with a large
increase in the frequency of EPSPs in slices from LPA1/mice
during the gamma rhythm (Fig. 3A). No change in kinetics (WT
decay time, 69.8 10.6ms; LPA1/ decay time, 69.6 19.3ms;
p 0.05; n
 6) or mean amplitude (WT peak amplitude, 2.5
0.3 ms; LPA1/ peak amplitude, 2.4 0.4 ms; p 0.05; n
 6)
of these EPSPs was seen, but a highly significant increase in fre-
quency from 1.7  0.1 to 2.5  0.1 Hz was apparent when WT
was compared with LPA1/ tissue ( p	 0.05; n
 6) (Fig. 3B).
Other models of psychosis in rodents have reported specific
reductions in parvalbumin-positive interneurons in prelimbic
areas (Cochran et al., 2002, 2003), so we examined whether the
decrease in functional inhibition seen in mEC tissue from
LPA1/ mice also could be attributable to a reduction in the
number of these interneurons. mEC slices from LPA1/ mice
showed that the total number of GABA-reactive cells was only
53% of WT number (WT, 84 12; LPA1/, 45 6; p	 0.05;
n
 8) (Fig. 4). This reduction in GABAergic interneuron num-
ber appeared to be predominantly attributable to a loss of
parvalbumin-positive neurons. In slices from LPA1/mice the
parvalbumin-immunoreactive cells were only 63% of the num-
ber found in WT slices (WT, 120  15; LPA1/, 77  8; p 	
0.05; n 
 8), whereas calretinin-immunoreactive cell numbers
were not significantly different (WT, 84 10; LPA1/, 89 9;
p 0.05; n
 5).
Because the decrease in inhibition-based gamma rhythms was
seen only in superficial mEC in tissue from LPA1/ mice, we
further analyzed the incidence of the above interneuron markers
in a lamina-specific manner. Cell bodies immunoreactive for
GABA, parvalbumin, and calretinin were quantified in LII/LIII
and deep layers below lamina dissecans. In LPA1/ tissue a
decrease in the number of GABA-reactive cells per unit area was
seen in LII when compared with WT slices (LPA1/, 3020 
285 mm2; WT, 4656 391 mm2; p	 0.05). The majority of
this decrease inGABA-reactive neuronswas correlated selectively
with a decrease in parvalbumin-immunoreactive cell bodies
(LPA1/, 3687  206 mm2; WT, 5198  336 mm2; p 	
0.05), but not calretinin (LPA1/, 3097  365 mm2; WT,
3255  407 mm2; p  0.05). This decrease in parvalbumin-
positive GABAergic neurons was selective for LII. No significant
differences were seen for parvalbumin-reactive neurons
Figure 3. Elevated excitatory activity in superficialmEC layers in slices from LPA1/mice.
A, Example traces showing altered spike generation and EPSP inputs to stellate cells during
populationgammaoscillations in control (WT, left panel) and LPA1/ (KO, right panel) slices.
Spike trains were taken at restingmembrane potential (58mV) in each case. Cells were held
at70 mV for EPSP recordings. Note the large increase in both excitatory input and spike
output in these cells. Calibration: 10 mV, 200 ms (action potentials, top panels); 2 mV, 50 ms
(EPSPs, bottom panels). B, Cumulative probability plots for EPSP data showing no significant
change in decay time or peak amplitude but a large increase in the rate of EPSP invasion of
stellate cells from LPA1/mice (KO) compared with controls (WT).
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(LPA1/, 5187  512 mm2; WT, 5366  570 mm2; p 
0.05) or calretinin-reactive neurons (LPA1/, 3089  340
mm2; WT, 2958 261mm2; p 0.05) in LIII. In deep layers,
where no change in gamma rhythms was seen, no significant
change in parvalbumin-reactive cell body numbers was seen ei-
ther (LPA1/, 2960 226mm2;WT, 2811 197mm2; p
0.05). Interestingly, a decrease in the mean number of calretinin-
immunopositive cell bodies was seen; however, this change did
not reach significance in the present study (LPA1/, 2006 195
mm2; WT, 2409 174 mm2; p 0.05).
Hippocampal gamma rhythms
In contrast to the superficial layers of the mEC, bath application
of kainate (50–300 nM) generated similar robust field oscillations
in the gamma band in slices from both WT and LPA1/ mice
(Fig. 5A). Peak frequency was 25.8 2.1 Hz for slices from WT
mice and 26.0 1.9Hz for LPA1/ tissue ( p 0.05; n
 12). A
small decrease in mean peak power and area of the kainate-
induced gamma rhythm was seen at a concentration of 200 nM,
but this did not reach significance (WT area, 4856.1  1130.3
V2; LPA1/ area, 3507.4  1021.3 V2; p  0.05; n 
 12)
(Fig. 5B).
Generation of gamma rhythms in the hippocampus has been
shown to be related closely to the output from fast-spiking inter-
neurons (Fisahn et al., 1998; Gloveli et al., 2005). We therefore
also quantified the number of GABA-, calretinin-, and
parvalbumin-positive interneurons in cornu ammonis in slices
after the above electrophysiological measurements and com-
pared these values with those for the total number of GABA-
positive cells and calretinin-positive cells (Fig. 6). No significant
difference was found in the total number of GABA-positive neu-
rons that were labeled (WT GABA neurons, 70  7; LPA1/
GABA neurons, 66  10; p  0.5; n 
 7). No change in the
number of parvalbumin-positive interneurons was seen (WT,
39  8; LPA1/, 36  12; p  0.5; n 
 8) or the number of
calretinin-positive cells (WT, 64 5; LPA1/, 61 11; p 0.5;
n
 5).
Comparison with acute ketamine application
Acute administration of noncompetitive NMDA receptors an-
tagonists is accepted as a good acute model of psychosis and both
positive and negative symptoms of schizophrenia in both hu-
mans (Adler et al., 1999) and animals (Adams and Moghaddam,
1998). Given the similarities between the behavioral and neuro-
chemical profile of LPA1/mice and clinical observations from
schizophrenic patients (Harrison et al., 2003) and the existence of
specific interneuron subtypes in LII of the entorhinal cortex with
strong NMDA receptor-mediated drive (Jones and Buhl, 1993),
we compared themain findings above from slices from LPA1/
mice with effects of acute exposure of control slices (from
C57BL/6J mice and Wistar rats) to ketamine (10–50 M). In the
superficial layers of themEC the concentrations of ketamine at or
above 20 M produced a significant reduction in the power of
field gamma oscillations generated by 400 nM kainate (Fig. 7A).
Bath application of 20 M ketamine reduced the area power in
superficial mEC from 352.2  64.3 to 199.7  55.7 V2 ( p 	
0.01; n 
 7) and caused a small but nonsignificant change in
mean frequency from 45 3 to 39 6 Hz ( p 0.05; n
 7). In
contrast, no significant change in the power of field gamma os-
cillations in the deep mEC was seen at any ketamine concentra-
tion that was tested ( p 0.05; n
 7). Similarly, ketamine bath
application produced no significant change in the power (Fig.
7B) and area power of kainate-induced persistent field gamma
oscillations in area CA1 or CA3 in the hippocampus (control
area, 11352 583.0 V2; 20 M ketamine area, 10414.3 511.5
V2; p  0.05; n 
 5). These data showed that the anatomical
profile of deficiencies in gamma rhythmogenesis in LPA1/
mice was similar to that generated by acute, noncompetitive
blockade of NMDA receptors. In the LPA1/ model the de-
crease in gamma activity in superficial layers was associated with
a decrease in IPSPs in principal cells and a concurrent increase in
neuronal output. This also was seen with bath application of
ketamine (Fig. 8) and again was accompanied by an increase in
stellate cell membrane resistance (control, 27  3; ketamine,
38  2 M; p 	 0.05; n 
 5). The same pattern of effects of
ketamine application was seen in slices from both rats and mice.
Discussion
Using two animalmodels of symptoms of schizophrenia, we have
demonstrated a spatially selective disruption in the generation of
Figure 4. LPA1/ mice show reduced parvalbumin-immunoreactive interneuron num-
bers inmEC. Shown is the distribution of parvalbumin-immunoreactive neurons in the entorhi-
nal cortex of WT (A) and KO (B) mice. Parvalbumin-immunoreactive cells were counted in
microscopic view fields, as shown in example panels. KO entorhinal cortex (B) showed a de-
crease in thenumber of parvalbumin-immunoreactiveneurons in layer II comparedwithWT (A)
(see Results). I–III, V, Layers I–III and V; LD, lamina dissecans. Scale bar: (in B) A, B, 65m.
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gamma frequency network oscillations in the entorhinal cortex.
In the case of both LPA1/ mice and a bath application of
ketamine the gamma oscillations were reduced in power in the
superficial layers, whereas deep layer oscillations were relatively
spared. In LPA1/mice this disruption in gamma rhythms was
accompanied by a selective reduction in parvalbumin-
immunopositive GABAergic cell bodies in LII, and in the pres-
ence of ketamine the superficial interneuron output was reduced.
In neither model was a change in gamma activity or parvalbumin
immunoreactivity seen in isolated hippocampal slices.
Gamma oscillations have been associated with sensory pro-
cessing for a number of years. Original studies by Singer andGray
(1995) demonstrated that a synchronous pattern of neuronal
output fromneurons in anatomically disparate areas of the cortex
occurs at gamma frequencies in response to object perception in
the sensorium (Engel et al., 1991; Rodriguez et al., 1999). Motor
performance also is associated with changes in gamma activity
(Aoki et al., 1999), and the interaction between sensory and mo-
tor systems probed by prepulse inhibition of startle tests (which
reveal sensorimotor-gating deficits in schizophrenia) involves
the entorhinal cortex (Goto et al., 2002). More recent work has
Figure 5. Power of hippocampal gamma rhythms is unchanged in slices from LPA1/
mice.A, Example extracellular recordings showing lack of difference in gamma rhythms gener-
atedby100and300nMkainate inhippocampal areaCA3 stratumradiatum. Calibration: 0.1mV,
100 ms. B, Pooled data plots (mean SEM; n
 5) for the area power and peak frequency of
field potential oscillations as a functionof kainate concentration.Noeffects are seenwhen slices
from control mice (solid lines) and LPA1/mice are compared (dashed lines).
Figure 6. Numbers of parvalbumin-immunopositive interneurons are unchanged in area
CA3 from LPA1/ mice. The distribution of parvalbumin-immunoreactive neurons in area
CA3 of WT (A) and KO (B) mice is shown. Parvalbumin-immunopositive cells were counted in
microscopic view fields, as shown in examplepanels of CA3 region.No significant changes in the
number of parvalbumin-immunopositive neurons were observed between WT (A) and KO (B)
hippocampus (see Results). so, Stratum oriens; P, stratum pyramidale; sl, stratum lucidum; sr,
stratum radiatum; slm, stratum lacunosum-moleculare. Scale bar: (in B) A, B, 140m.
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indicated that this pattern of synchronous network activity at
gamma frequencies is linked inherently to processes involved in
aspects of short-term memory (working memory, declarative
memory) (Miltner et al., 1999), context representation and atten-
tion (Tiitinen et al., 1993; Borgers et al., 2005), and themismatch
negativity response (Marshall et al., 1996). Each of these pro-
cesses also is disrupted in patients with psychiatric illness (Wein-
berger et al., 1986; Elvevag and Goldberg, 2000). In terms of
deficits in gamma rhythmogenesis specifically related to schizo-
phrenia, work fromMcCarley and coworkers has shown a deficit
in gamma rhythm generation and associated synchrony in the
neocortex during visual and auditory processing tasks (Spencer et
al., 2003, 2004).
The generation of persistent gamma rhythms in the entorhi-
nal cortex hasmechanistic similarities to those seen in hippocam-
pus (Whittington et al., 1995; Fisahn et al., 1998; Cunningham et
al., 2003). Basically, ongoing axonal activity in principal neuronal
axons provides a drive to GABAergic interneurons. The resulting
output from a subset of these interneurons targeting principal
cell somata and axonal initial segments serves to modulate prin-
cipal cell firing patterns phasically so that the highest probability
of spike generation occurs approximately once every 25 ms
(Whittington and Traub, 2003). The interneuron subtypes im-
plicated in thismechanismall target the principal cell perisomatic
region, and most are immunopositive for parvalbumin (Gloveli
et al., 2005; Mann et al., 2005). Markers for these interneuron
subtypes are reduced significantly in prefrontal cortical areas in
Figure 7. Ketamine application to control slices mimics the anatomical profile of disrupted
gamma rhythms seen in LPA1/ slices.A, Example traces show0.5 s of field potential activity
in superficial (layer II) and deep (layer IV/V) laminas in the presence and absence of ketamine
(20 M). Calibration: 50 V, 100 ms. Pooled power spectra (n
 7) illustrate the selective
reduction in gamma frequency oscillations in superficial entorhinal cortex. B, Example traces
show 0.5 s of field potential activity in hippocampal area CA3 in the presence and absence of
ketamine (20 M). Calibration: 50 V, 100 ms. Pooled power spectra (n
 7) show lack of
effect of ketamineonhippocampal gamma rhythms. Control data are plotted as solid lines; data
gathered in the presence of ketamine are plotted as dashed lines.
Figure 8. Ketamine-induced reduction in gamma rhythmogenesis is accompanied by disin-
hibition.A, IPSP trains associatedwith the field gamma rhythmare disrupted in the presence of
ketamine. Example traces show stellate cell IPSPs recorded from30mVmembrane potential
in the presence and absence of ketamine (20M). Calibration: 2 mV, 50 ms. The graph shows
power spectra from 60 s epochs of stellate cell IPSP trains in control (solid line) and ketamine
(gray line) conditions. Note the large reduction in activity within the gamma band. B,
Ketamine-induced disruption in gamma oscillations is associated with increased stellate cell
output. Example traces show stellate cell spiking at resting membrane potential (57 and
59 mV) in the presence and absence of ketamine (20M; top traces). Bottom traces show
EPSPs at70mVmembranepotential in the two conditions. Note the different time axis in the
spike and EPSP traces. Calibration: 10 mV, 200 ms (spike traces); 2 mV, 50 ms (EPSP traces).
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schizophrenics, and some similar changes have been reported in
entorhinal cortex (Arnold, 2000). Glutamic acid decarboxylase
isoform 67 (GAD67), a general marker for GABAergic interneu-
rons, is reduced selectively in gamma-generating layers of cortex
(Akbarian et al., 1995). Also, GABA transporter 1 (GAT1) is de-
creased in the same areas (Volk et al., 2001), suggesting that both
synthesis and reuptake of GABA are disrupted in schizophrenics.
The origins of this disruption appear to coincide with a reduction
in parvalbumin signal (Hashimoto et al., 2003). Although the
number of parvalbumin-positive neurons is unchanged, the
function of these neurons appears to be disrupted significantly.
In particular, chandelier cells, which provide very strong feed-
back inhibition to axons via chains of inhibitory synapses (car-
tridges), do so to a much lesser extent in schizophrenia (Woo et
al., 1998). It is not clear as yet why subtypes of interneuron are
susceptible in schizophrenia and the LPA1 knock-out mice. Evi-
dence for differences in excitatory amino acid receptors on inter-
neurons has been suggested in hippocampus (Grunze et al.,
1996). The similarities between the functional deficits in
LPA1/ mice and acute application of ketamine suggest a role
forNMDAreceptors, butwhich subtypes are responsible remains
to be elucidated.
The present study provides evidence for a similar mechanism
at work in the entorhinal cortex. The loss of parvalbumin signal
in LII medial entorhinal cortex of LPA1/ mice, coupled with
the enhanced excitability of superficial principal neurons and the
reduction in inhibitory control over principal neurons (both
during gamma rhythms and evoked by electrical stimulation),
suggests that a selective reduction in perisomatic inhibition may
underlie the deficits in gamma rhythmogenesis. LPA1 receptor
expression is regulated developmentally (Weiner et al., 1998).
LPA1 expression is high before birth, disappears at birth, then
reappears during the first postnatal week and peaks at postnatal
day 18. The expression profile of LPA1 after birth parallels the
expression profile of other markers associated with interneuron
function. For instance, parvalbumin expression and the Kv3.1b
potassium channel expression in interneurons start toward the
end of the first postnatal week and tend to peak in the second–
third week, similar to LPA1 (Bergmann et al., 1991; Du et al.,
1996). LPA1 expression also has been associated with the gener-
ation of neurons from progenitor cells and their subsequent mi-
gration and survival (Kingsbury et al., 2003). Although not spe-
cific for parvalbumin-positive neurons, the absence of LPA1
receptors may have a predominant effect on network function
associated with these cells because they are highly active and have
such a large effect on population responses and there are, rela-
tively, very few of them. The correlation among the degree of loss
of parvalbumin signal, principal cell inhibition, and the power of
gamma rhythms (40% in each case) supports this notion.
The similarity between the deficits in network function seen in
the LPA1/ mice and with acute application of ketamine sug-
gests that the function of LII parvalbumin-immunopositive in-
terneurons also was disrupted in this model. Noncompetitive
NMDA receptor antagonists generate psychomotor-gating defi-
cits and other behavioral responses closely associated with
schizophrenia (Ellison, 1995) and selectively enhance c-fos ex-
pression in entorhinal and prefrontal areas (Vaisanen et al.,
2004). Parvalbumin-immunopositive basket cells in LII entorhi-
nal cortex are activated strongly by NMDA receptor agonists
(Jones and Buhl, 1993), and these cells possess a marked tonic
excitatory component to their drive during gamma oscillations
(Cunningham et al., 2003). Blockade of NMDA receptors with
ketamine reduces the output from superficial basket cells concur-
rently with a selective drop in gamma power in superficial layers.
Disinhibition of the entorhinal cortex also has been reported in
slices from rats pretreatedwithNMDA receptor antagonists (Du-
gladze et al., 2004). It is not clearwhy ketamine produces a similar
pattern of selective reduction of gamma power in superficial lay-
ers. Too little is known at present about interneuron subtypes and
distribution to suggest different inhibitory circuits in deep and
superficial layers. However, it is interesting to note that sponta-
neous inhibitory events are different in the two layers (Woodhall
et al., 2005) and that synaptic plasticity also is expressed differen-
tially (Solger et al., 2004).
The lack of effect of either model on hippocampal gamma
rhythmogenesis is in stark contrast to the observations in ento-
rhinal cortex. The hippocampus has many parvalbumin-positive
interneurons (Gulyas et al., 1991), but their number appears to be
inert to the removal of the LPA1 receptor. The reasons for this
remain to be resolved, but it is interesting to consider that, in
contrast to parvalbumin-positive interneurons in the superficial
entorhinal cortex, neurons with this signal in adult hippocampus
receive relatively little drive via NMDA receptors (Nyiri et al.,
2003) (A. Rozov andH.Monyer, personal communication). This
also may be related to the lack of effect of NMDA receptor antag-
onists on hippocampal gamma (Fisahn et al., 1998). Postmortem
studies of hippocampi from schizophrenic patients show selec-
tive reduction in parvalbumin-positive neurons in all hippocam-
pal subfields, whereas calretinin-positive cells remain unchanged
(Zhang andReynolds, 2002; Knable et al., 2004).No such changes
in parvalbumin signal were seen in either of the two models that
were used, suggesting that the LPA1 receptor transduction path-
way is not responsible for the above changes in humans. Ket-
amine has been reported to reduce hippocampal parvalbumin
signal after repeated exposure (Keilhoff et al., 2004) in rodents,
suggesting that the duration of exposure in the present study
(4–8 h) was insufficient to precipitate such changes. However, in
vivo the change in superficial layer network activity would be
expected to influence hippocampal rhythmicity. Ketamine ad-
ministration or lesion of entorhinal–hippocampal connectivity
results in a change in the profile of oscillations in cornu ammonis
(Charpak et al., 1995; Ylinen et al., 1995).
In summary, twomodels of psychiatric illness associated with
sensorimotor-gating deficit generated a pattern of disruption in
gamma rhythms specific to the superficial entorhinal cortex. In
each case the disruption was accompanied by an apparent reduc-
tion in parvalbumin-immunopositive interneurons or a decrease
in output of fast-spiking superficial entorhinal interneurons.
Given that these interneurons have been shown to have a rela-
tively powerful input via NMDA receptors, we speculate that
specific functional deficits in this subset of fast-spiking inhibitory
cells may underlie some of the behavioral correlates of cortical
dysfunction seen in psychosis.
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